Pfoolishly’s Activity

Fri Mar 3

NL

Article

Pfoolishly published an article 6:35 PM

The Best Bet in the Growing Genetic Testing Market: Genetic Health vs. Invitae

Which company is best situated to profit off this secular growth trend?

Sun Feb 26

NL

Article

Pfoolishly published an article 6:20 PM

Has Biodelivery Sciences Finally Turned the Corner?

Will Biodelivery Sciences have any more success commercializing Belbuca?

Thu Feb 23

NL

Article

Pfoolishly published an article 11:46 PM

Can Shares of Aquinox Pharmaceuticals Continue to Rocket Higher?

Will this past failure lead to a future success story?

Sat Feb 18

NL

Article

Pfoolishly published an article 3:54 PM

Can This Marijuana Stock Add Some Green to Your Portfolio? A Closer Look at Corbus Pharmaceuticals

After a 600% rally, can shares continue to move higher?

Fri Feb 10

NL

Article

Pfoolishly published an article 8:29 PM

What This Legendary Value Investor Thinks About the Markets Right Now

When Seth Klarman speaks, the market listens.

Wed Feb 8

NL

Article

Pfoolishly published an article 6:02 PM

Why Shares of Cara Therapeutics Are Up Over 75% Since the Start of 2017

After a meteoric rise since the start of the year, can these shares keep climbing?

Tue Feb 7

NL

Article

Pfoolishly published an article 8:02 PM

Riding High? Or Just a Puff of Smoke? A Closer Look at Medical Marijuana Inc.

How risky is this play on the growing cannabis industry?

NL

Article

Pfoolishly published an article 7:07 PM

A Potential $20 Billion Indication? 2 Must-Have Biotechs Taking on Alzheimer's Disease

Is biotech giant Biogen or scrappy startup Acadia the better buy in Alzheimer's?

Mon Jan 30

NL

Article

Pfoolishly published an article 1:29 PM

Pacific Biosciences: A Small Cap Gem in the Genomics Market

Does a better product mean Pacific Biosciences is finally ready to take on Illumina?

Thu Jan 19

NL

Article

Pfoolishly published an article 9:52 AM

Did Roche Just Hand Illumina Pacific Biosciences’ Head on a Platter?

What does Roche’s partnership termination with Pacific Biosciences mean for Illumina shareholders?

Tue Jan 17

NL

Article

Pfoolishly published an article 9:21 AM

The Worst Performing Stock of 2016

What's next for Endo Pharmaceuticals?

Tue Dec 27

NL

Article

Pfoolishly published an article 2:19 PM

A David and Goliath Story: Can Small-Cap Synergy Pharmaceuticals Take on Ironwood Pharmaceuticals?

Has the success of Synergy Pharmaceuticals' plecanatide put Ironwood on the warpath?

Sun Dec 25

NL

Article

Pfoolishly published an article 9:15 PM

Did Biogen Just Throw in the Towel to Celgene?

Was the failure of MT-1303 the last stone in Biogen's crumbling autoimmune empire?

Wed Nov 23

NL

Article

Pfoolishly published an article 12:20 PM

2 Red-Hot Biotechs to Buy Ahead of FDA Decisions

Is it worth rolling the dice on Flexion and Synergy?

Tue Nov 15

NL

Article

Pfoolishly published an article 2:47 PM

Can Flexion Therapeutics Add Some Muscle to Your Portfolio?

Shares of small-cap Flexion Therapeutics have rallied more than 100% in the past six months. Is there more upside to come?

Wed Nov 2

NL

Article

Pfoolishly published an article 5:36 AM

3 Reasons to Sell Biogen

Increasing competition within the multiple sclerosis market makes Biogen king of a crumbling empire. Is it time to ring the register?

Fri Oct 28

NL

Article

Pfoolishly published an article 3:34 AM

2 Beaten-Up Biotech Blue Chip Stocks on Sale Today

Fresh off better-than-expected Q3 earnings, are Bristol-Myers and Celgene still bargains?

Tue Oct 18

NL

Article

Pfoolishly published an article 2:30 PM

3 Reasons Bristol-Myers Is a Buy

Is Opdivo on track to Opd-imize your portfolio?

Thu Oct 13

NL

Article

Pfoolishly published an article 9:48 AM

Buy on the Dip? 3 Reasons to Buy Illumina and Never Sell

With the recent pullback, Illumina shares are looking more attractive than ever for long-term investors.

Mon Oct 10

NL

Article

Pfoolishly published an article 8:41 AM

Better Buy: Biogen vs. Celgene

Celgene is looking to move into Biogen's multiple sclerosis empire. See which one of these biotech behemoths is the better choice for your portfolio.

Show More Activity ...

CAPS Stats & Trivia

CAPS Player Rating < 20
Player Rank 0 out of 69553
Score 0.00
Score Change Today 0
Accuracy 0.00%
Active Picks 0
Total Picks 0
Best Pick ( 0)
Worst Pick ( 0)
Average Score per Pick 0.00
Charms Earned 0
Highest Rated Favorite No Favorites Selected
Go to Pfoolishly’s CAPS page

Boards Stats & Trivia

Board Posts 0
Recs Received 0
People who have rec'd these posts 0
Recs to Posts Ratio (last 30 days) N/A
Threads Started 0
Threads Started Percentage 0.00 %
Most Frequent Board N/A
Very First Post N/A
Percentage of Posts Rec'd 100.00 %
Show Pfoolishly’s 10 Latest Posts